Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Eflornithine cream makes laser hair removal more effective for treating pseudofolliculitis barbae.

Epiregulin can help hair grow and may be useful for treating hair loss.

Topical eflornithine helps maintain hair reduction after IPL therapy in women with facial hirsutism.

Some gonadal hormone drugs can block filovirus entry into cells.

Estetrol may help prevent hair loss and promote hair growth in women.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Epidermal growth factor slows hair and body growth in mice.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Blocking IL-8 can reduce skin rashes from cancer treatment.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.